1/22
Vocabulary practice flashcards covering inborn errors of amino acid metabolism, transport defects, aromatic and branched-chain amino acid catabolic disorders, and sulfur amino acid enzyme deficiencies.
Inborn Errors of Metabolism (IEM)
A group of genetic conditions caused by gene mutations that result in defective or deficient enzymes, leading to a total loss or partial deficiency in enzymatic activity.
Aminoaciduria
The excessive excretion of amino acids in the urine caused by a defect in renal transport proteins that normally reabsorb filtered amino acids in the kidney tubules.
Hartnup Disease
An autosomal recessive disorder caused by defective transport of neutral amino acids (such as tryptophan) across the brush border of the small intestine and renal proximal tubules, resulting in aminoaciduria and pellagra-like symptoms.
Cystinuria
An inherited disorder characterized by defective membrane transport and excessive urinary excretion of cystine along with the dibasic amino acids ornithine, lysine, and arginine.
Glycinuria
An amino acid transport disorder characterized by defective renal handling and increased urinary excretion of glycine and the imino acids proline and hydroxyproline.
Phenylketonuria (PKU)
An autosomal recessive inborn error of metabolism caused by an inability to catabolize phenylalanine, leading to toxic accumulations of phenylalanine in the blood, brain, and other tissues.
Phenylalanine Hydroxylase (PAH)
The rate-limiting hepatic enzyme that catalyzes the hydroxylation of L-phenylalanine to L-tyrosine; mutations in its gene cause classic phenylketonuria (Hyperphenylalaninemia Type I).
Atypical PKU (Malignant PKU)
A severe form of hyperphenylalaninemia caused by a deficiency in tetrahydrobiopterin (BH4) or dihydropteridine reductase rather than a defect in the phenylalanine hydroxylase apoenzyme itself.
Dihydropteridine Reductase
The enzyme responsible for regenerating active tetrahydrobiopterin (BH4) from dihydrobiopterin (BH2); its deficiency causes Hyperphenylalaninemia Types II and III.
Phenylketones
Alternative catabolic metabolites of accumulated phenylalanine—including phenylpyruvate, phenyllactate, and phenylacetate—that are excreted in urine and produce a characteristic musty or mousey odor.
Type I Tyrosinemia
A severe inborn error of metabolism caused by a defect in fumarylacetoacetate hydrolase, causing elevated plasma tyrosine and accumulation of hepatotoxic metabolites that can cause fatal liver failure within the first year of life.
Type II Tyrosinemia
A metabolic disorder caused by a deficiency in tyrosine aminotransferase, the enzyme responsible for transaminating tyrosine to p-hydroxyphenylpyruvate.
Alkaptonuria
A rare metabolic disorder caused by a deficiency of homogentisic acid oxidase, leading to the accumulation of homogentisic acid, darkening of urine upon exposure to air, ochronosis, and early-onset osteoarthritis.

Ochronosis
The deposition of dense, black pigment in collagenous tissues and cartilage caused by the oxidation and polymerization of homogentisic acid into benzoquinone acetate in alkaptonuria.
Albinism
A disorder of tyrosine metabolism resulting in defective melanin synthesis, leading to partial or complete absence of pigment in the skin, hair, and eyes, along with visual defects and increased susceptibility to skin cancer.
Tyrosinase
The copper-dependent enzyme required for converting L-tyrosine and L-DOPA to dopaquinone in the pathway for eumelanin and phaeomelanin synthesis; deficient in forms of albinism.
Branched-Chain Amino Acids (BCAAs)
The essential hydrophobic amino acids leucine, isoleucine, and valine, whose breakdown is disrupted in maple syrup urine disease.
Maple Syrup Urine Disease (MSUD)
An autosomal recessive disorder caused by a deficiency in the branched-chain α-keto acid dehydrogenase complex, presenting in early infancy with sweet-smelling urine and earwax, vomiting, lethargy, encephalopathy, and neurotoxicity.
Branched-Chain α-Keto Acid Dehydrogenase Complex (BCKDH)
A multi-enzyme complex responsible for the oxidative decarboxylation of branched-chain α-keto acids (derived from leucine, isoleucine, and valine) into their respective branched-chain acyl-CoA thioesters.
Homocystinuria
An autosomal recessive defect in homocysteine catabolism—most frequently caused by deficiency of cystathionine β-synthase—manifesting with elevated plasma homocysteine and methionine, skeletal abnormalities, thrombosis, and lens dislocation.
Cystathionine β-Synthase (CBS)
The pyridoxal phosphate (vitamin B6)-dependent enzyme that catalyzes the condensation of homocysteine and serine to form cystathionine; its deficiency causes classic Type I homocystinuria.
Pyridoxine-Responsive Homocystinuria
A form of homocystinuria in which a mutant cystathionine β-synthase enzyme has reduced affinity for its cofactor (pyridoxal phosphate) and can be stabilized and activated by high therapeutic doses of vitamin B6.
Cystathionuria
An inborn error of sulfur amino acid metabolism caused by a deficiency in cystathionase, the enzyme that cleaves cystathionine into cysteine and α-ketobutyrate.